What is he best known for?
The fields of study he is best known for:
- Antibiotics
- Bacteria
- Internal medicine
His scientific interests lie mostly in Microbiology, Antibacterial agent, Ciprofloxacin, Antibiotic resistance and Pharmacology.
His studies in Microbiology integrate themes in fields like Ceftazidime and Klebsiella pneumoniae.
His Antibacterial agent research incorporates themes from Multiple drug resistance and Drug resistance.
His Antibiotic resistance study combines topics in areas such as Penicillin, Streptococcus pneumoniae and Ceftriaxone.
His studies deal with areas such as Minimum inhibitory concentration, Anaerobic bacteria and Avibactam as well as Pharmacology.
His work deals with themes such as Cefepime and Imipenem, which intersect with Meropenem.
His most cited work include:
- Comparative review of the carbapenems. (394 citations)
- Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States (325 citations)
- Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001 (320 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Microbiology, Antibacterial agent, Broth microdilution, Antimicrobial and Streptococcus pneumoniae.
The concepts of his Microbiology study are interwoven with issues in Pseudomonas aeruginosa and Klebsiella pneumoniae.
His research integrates issues of Vancomycin, Minimum inhibitory concentration, Aminoglycoside and Levofloxacin in his study of Antibacterial agent.
His work investigates the relationship between Broth microdilution and topics such as Meropenem that intersect with problems in Colistin and Tigecycline.
His Streptococcus pneumoniae study combines topics from a wide range of disciplines, such as Haemophilus influenzae, Virology, Penicillin, Staphylococcus aureus and Ceftriaxone.
James A. Karlowsky interconnects Pharmacology and Bacteria in the investigation of issues within Antibiotics.
He most often published in these fields:
- Microbiology (83.99%)
- Antibacterial agent (22.47%)
- Broth microdilution (22.47%)
What were the highlights of his more recent work (between 2018-2021)?
- Microbiology (83.99%)
- Broth microdilution (22.47%)
- Pseudomonas aeruginosa (18.82%)
In recent papers he was focusing on the following fields of study:
James A. Karlowsky mainly investigates Microbiology, Broth microdilution, Pseudomonas aeruginosa, Klebsiella pneumoniae and Imipenem.
His study in Microbiology is interdisciplinary in nature, drawing from both Bacilli and Escherichia coli.
His Broth microdilution study incorporates themes from Ciprofloxacin, Clindamycin, Cefepime, Genotype and Drug resistance.
His work carried out in the field of Pseudomonas aeruginosa brings together such families of science as Multiple drug resistance, Enterobacteriaceae and Intensive care.
His research in Klebsiella pneumoniae intersects with topics in Amikacin and Antibiotic resistance, Meropenem.
The study incorporates disciplines such as Ceftazidime and Serratia marcescens in addition to Imipenem.
Between 2018 and 2021, his most popular works were:
- Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli (94 citations)
- In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015. (46 citations)
- Microbiology and Preclinical Review of Omadacycline. (18 citations)
In his most recent research, the most cited papers focused on:
- Antibiotics
- Bacteria
- Internal medicine
The scientist’s investigation covers issues in Microbiology, Broth microdilution, Pseudomonas aeruginosa, Imipenem and Bacilli.
His research in Ceftolozane, Tazobactam, Colistin, Enterococcus and Antimicrobial are components of Microbiology.
His biological study spans a wide range of topics, including Sulfamethoxazole, Staphylococcus haemolyticus, Klebsiella pneumoniae and Trimethoprim.
The various areas that he examines in his Imipenem study include Ceftazidime and Multiple drug resistance.
James A. Karlowsky has included themes like Acinetobacter baumannii and Pharmacology in his Ceftazidime study.
His Bacilli research is multidisciplinary, incorporating elements of Enterobacteriaceae and Cephalosporin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
